Andy Rignall

Articles by Andy Rignall

Evaluating Progress in Analytical Quality by Design

ByElizabeth Hewitt,Andy Rignall,Mark D. Trone,Patrick Jackson,Marion Chatfield,Mark Argentine,Qinggang Wang,Shreekant Karmarkar,Andrea M. Pless,Zeena Williams,Kimber Barnett,David Semin,Yanqun Zhao,Ariane Marolewski

April 2nd 2017

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.

Early Development GMPs for Stability (Part IV)

ByQ. Chan Li,Z. Jane Li,Tony Mazzeo,Robert Timpano,Mark Alasandro,Stephen Colgan,Andy Rignall,Z. Jessica Tan,Frank Diana,Bruce Acken,Paul Curry

September 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.

GMPs for Small-Molecule Drugs in Early Development (Part I)

ByTony Mazzeo,Amnon Eylath,John W. Skoug,Brent Kleintop,Andy Rignall,James S. McElvain

June 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Latest Updated Articles

Early Development GMPs for Stability (Part IV)
Published: September 2nd 2012 | Updated:
GMPs for Small-Molecule Drugs in Early Development (Part I)
Published: June 2nd 2012 | Updated:
Evaluating Progress in Analytical Quality by Design
Published: April 2nd 2017 | Updated: